Avanos Medical, Inc. (AVNS) — Dilution Risk Analysis
Current Snapshot
Avanos Medical, Inc. (AVNS) has a DilutionWatch score of 24/10 and is classified as LOW risk. The score date in the source data is 2026-09-18T03:44:14.301914.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 24/10 Source (as of 2026-09-18T03:44:14.301914)
Recent SEC Filings
Recent filing forms in the source payload: 4 8.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-03-17 | 0001606498-26-000023 |
| 4 | 2026-03-17 | 0001606498-26-000025 |
| 4 | 2026-03-17 | 0001606498-26-000027 |
| 4 | 2026-03-17 | 0001606498-26-000029 |
| 4 | 2026-03-11 | 0001606498-26-000014 |
| 4 | 2026-03-11 | 0001606498-26-000015 |
| 4 | 2026-03-10 | 0001606498-26-000010 |
| 4 | 2026-03-10 | 0001606498-26-000011 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 562 months | Source |
| Three-year share count growth | 0.86% | Source |
DilutionWatch Analysis
- Risk Level
- LOW (Score: 24/10) Source
- Cash Runway
- 562 months Source
- Share Count Growth (3-Year)
- 0.86% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.